In late 2014, the FDA approved Soolantra, a topical cream, for the treatment of acne rosacea associated with demodex mites. Ivermectin, the active ingredient in the cream, has both anti-inflammatory and antiparasitic activity. The basis for the cream is Cetaphil moisturizing cream.
An ophthalmic version has not yet been approved in the United States.
An emerging treatment: topical Ivermectin for papulopustular rosacea
Abokwidir M, Fleischer AB.
The Journal of Dermatological Treatment
2015;26(4):379-80. doi: 10.3109/09546634.2014.991672. Epub 2015 Jan 30.
View the full report